Study on an Investigational Yellow Fever Vaccine Compared with Stamaril in Adults in Europe and Asia

Trial Identifier: VYF03
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: October 2021
Primary Completion Date: May 2022
Study Completion Date: April 2027
Condition: Yellow Fever Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
FINLAND Helsinki, FINLAND, 00290
FINLAND TAMPERE, FINLAND, 33100
FINLAND TURKU, FINLAND, 20520
FRANCE Lyon, FRANCE, 69004
FRANCE MONTPELLIER, FRANCE, 34295
FRANCE Nantes, FRANCE, 44093
FRANCE Nimes, FRANCE, 30029
FRANCE PARIS, FRANCE, 75014
FRANCE PIERRE BENITE, FRANCE, 69495
GERMANY Berlin, GERMANY, 10117
GERMANY Hamburg, GERMANY, 20359
GERMANY München, GERMANY, 80802
GERMANY Rostock, GERMANY, 18057
SINGAPORE Singapore, SINGAPORE
SINGAPORE Singapore, SINGAPORE, 119074
SINGAPORE Singapore, SINGAPORE, 169608
SPAIN, Barcelona [Barcelona] Barcelona, Barcelona [Barcelona], SPAIN, 08035
SPAIN, Barcelona [Barcelona] Hospitalet de Llobregat, Barcelona [Barcelona], SPAIN, 08907
SPAIN, Madrid, Comunidad de Madrid, Madrid, Comunidad de, SPAIN, 28046
SPAIN, Not Known BARCELONA, Not Known, SPAIN, 08036
THAILAND Bangkok, THAILAND, 10330
THAILAND Bangkok, THAILAND
THAILAND Nonthaburi, THAILAND, 11000